US2020239955A1PendingUtilityA1

High-throughput nucleotide library sequencing

61
Assignee: ABVITRO LLCPriority: Sep 15, 2014Filed: Feb 3, 2020Published: Jul 30, 2020
Est. expirySep 15, 2034(~8.2 yrs left)· nominal 20-yr term from priority
C12Q 1/6869C12N 15/1093C12Q 2565/514C12Q 2525/179C12Q 1/6874C12Q 2563/179
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are methods and composition for immune repertoire sequencing and single cell barcoding. The methods and compositions can be used to pair any two sequences originating from a single cell, such as heavy and light chain antibody sequences, alpha and beta chain T-cell receptor sequences, or gamma and delta chain T-cell receptor sequences, for antibody and T-cell receptor discovery, disease and immune diagnostics, and low error sequencing.

Claims

exact text as granted — not AI-modified
1 - 525 . (canceled) 
     
     
         526 . A composition comprising a plurality of vessels, wherein at least one vessel of the plurality comprises:
 (a) a single cell from a sample comprising a plurality of cells;   (b) a plurality of molecular-barcoded oligonucleotide molecules;   (c) a vessel-barcoded oligonucleotide;   (d) a first polynucleotide comprising (i) a first molecular barcode sequence from a first molecular-barcoded oligonucleotide molecule of a plurality or a complement thereof, (ii) a vessel barcode sequence from the vessel barcoded oligonucleotide or a complement thereof, and (iii) a region complementary to a first cell polynucleotide from the single cell; and   (e) a second polynucleotide comprising (i) a second molecular barcode sequence from a second molecular-barcoded oligonucleotide molecule of the plurality or a complement thereof, (ii) the vessel barcode sequence from the vessel barcoded oligonucleotide or a complement thereof, and (iii) a region complementary to a second cell polynucleotide from the single cell;   wherein the molecular-barcoded oligonucleotide molecules of the plurality and the vessel-barcoded oligonucleotide are separate nucleic acid molecules.   
     
     
         527 . The composition of  claim 526 , wherein the first cell polynucleotide is a heavy chain immunoglobulin (IgH) polynucleotide, a T-cell receptor alpha (TCRα) polynucleotide, or a T-cell receptor gamma (TCRγ) polynucleotide; and wherein the second cell polynucleotide is a light chain immunoglobulin (IgL) polynucleotide, a T-cell receptor beta (TCRβ) polynucleotide, or a T-cell receptor delta (TCRδ) polynucleotide. 
     
     
         528 . The composition of  claim 526 , wherein the single cell is a B-cell or a T-cell. 
     
     
         529 . The composition of  claim 526 , wherein the first and the second polynucleotides in the at least one vessel of the plurality comprise different molecular barcode sequences. 
     
     
         530 . The composition of  claim 526 , wherein the molecular-barcoded oligonucleotide molecules of the plurality are not amplified products. 
     
     
         531 . The composition of  claim 526 , wherein a molecular barcode sequence of a molecular-barcoded oligonucleotide molecule of the plurality in a first vessel of the plurality is different than a molecular barcode sequence of a molecular-barcoded oligonucleotide molecule of the plurality in a second vessel of the plurality. 
     
     
         532 . The composition of  claim 526 , wherein a vessel barcode sequence of a vessel-barcoded oligonucleotide in a first vessel of the plurality is different from a vessel barcode sequence of a vessel-barcoded oligonucleotide in a second vessel of the plurality. 
     
     
         533 . The composition of  claim 526 , wherein the vessel-barcoded oligonucleotide in the at least one vessel of the plurality is present as a single molecule. 
     
     
         534 . The composition of  claim 526 , wherein the vessel barcode sequences of the first and the second polynucleotides in the at least one vessel of the plurality are the same. 
     
     
         535 . The composition of  claim 526 , wherein the vessel-barcoded oligonucleotides in two or more different vessels of the plurality comprise a first common-vessel sequence upstream of the vessel barcode sequence, a second common-vessel sequence downstream of the vessel barcode sequence, or both. 
     
     
         536 . The composition of  claim 526 , wherein each of the molecular-barcoded oligonucleotide molecules of the plurality in a same vessel of the plurality comprises a first common-molecular sequence upstream of the molecular barcode sequence, a second common-molecular sequence downstream of the molecular barcode sequence, or both. 
     
     
         537 . The composition of  claim 526 , wherein each of the molecular-barcoded oligonucleotide molecules of the plurality in each vessel of the plurality comprises a first common-molecular sequence upstream of the molecular barcode sequence, a second common-molecular sequence downstream of the molecular barcode sequence, or both. 
     
     
         538 . The composition of  claim 526 , wherein the vessel-barcoded oligonucleotide or a complement thereof comprises a sequence complementary to a region of a complement of each molecular-barcoded oligonucleotide molecule of the plurality. 
     
     
         539 . The composition of  claim 526 , wherein the vessel-barcoded oligonucleotide or a complement thereof comprises a sequence complementary to a 3′ end region of a first and a second molecular-barcoded polynucleotide. 
     
     
         540 . The composition of  claim 526 , wherein the vessels of the plurality are emulsions. 
     
     
         541 . The composition of  claim 526 , wherein the single cell is lysed. 
     
     
         542 . The composition of  claim 526 , wherein a first target primer, a second target primer, the vessel-barcoded oligonucleotide, the plurality of molecular-barcoded oligonucleotide molecules, or any combination thereof, is not attached to a solid support. 
     
     
         543 . The composition of  claim 526 , wherein the first and the second cell polynucleotides are RNA. 
     
     
         544 . The composition of  claim 526 , further comprising a non-template terminal transferase, a reverse transcriptase, a polymerase, or any combination thereof. 
     
     
         545 . The composition of  claim 526 , wherein the vessel-barcoded oligonucleotide is attached to a solid support.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.